Lindbrook Capital, LLC Stoke Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$7.93 - $13.82 $975 - $1,699	-123 Reduced 22.99%	412 $4,000
Q1 2023 Apr 26, 2023	SELL	$7.65 - $10.38 $175 - $238	-23 Reduced 4.12%	535 $4,000
Q4 2022 Jan 24, 2023	BUY	$7.07 - $15.69 $3,916 - $8,692	554 Added 13850.0%	558 $0
Q3 2022 Nov 10, 2022	BUY	$12.56 - $22.53 $50 - $90	4 New	4 $0
Q2 2022 Aug 01, 2022	SELL	$10.36 - $23.93 $1,046 - $2,416	-101 Closed	0 $0

Q1 2022 Apr 21, 2022	BUY	$17.19 - $26.1 $1,736 - $2,636	101 New	101 $2,000

111

50M

63K

111K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $533M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.